A recent study suggest that Lipoxins (LXs) and analogues exert strong analgesic effects on cancer-induced bone pain (CIBP) and suppress the pain associated expression of spinal proinflammatory cytokines (IL-1β and TNF-α) [31]. This evidence concerns the gene TNF and cancer.